Third Coast Bancshares (TCBX) Competitors

Cellectis (NASDAQ:CLLS) and Third Coast Bancshares (NASDAQ:TCBX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation.

Does the media refer more to CLLS or TCBX?

In the previous week, Cellectis and Cellectis both had 1 articles in the media. Third Coast Bancshares' average media sentiment score of 1.45 beat Cellectis' score of 0.00 indicating that Third Coast Bancshares is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellectis	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Third Coast Bancshares	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of CLLS or TCBX?

63.9% of Cellectis shares are owned by institutional investors. Comparatively, 36.9% of Third Coast Bancshares shares are owned by institutional investors. 16.4% of Cellectis shares are owned by company insiders. Comparatively, 10.2% of Third Coast Bancshares shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more risk and volatility, CLLS or TCBX?

Cellectis has a beta of 3.1, suggesting that its stock price is 210% more volatile than the S&P 500. Comparatively, Third Coast Bancshares has a beta of 0.27, suggesting that its stock price is 73% less volatile than the S&P 500.

Do analysts rate CLLS or TCBX?

Cellectis currently has a consensus target price of $7.00, indicating a potential upside of 266.49%. Third Coast Bancshares has a consensus target price of $25.33, indicating a potential downside of 28.96%. Given Cellectis' stronger consensus rating and higher possible upside, research analysts clearly believe Cellectis is more favorable than Third Coast Bancshares.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellectis	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Third Coast Bancshares	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the MarketBeat Community favor CLLS or TCBX?

Cellectis received 393 more outperform votes than Third Coast Bancshares when rated by MarketBeat users. Likewise, 65.65% of users gave Cellectis an outperform vote while only 53.85% of users gave Third Coast Bancshares an outperform vote.

Company	Underperform	Outperform
Cellectis	Outperform Votes 407 65.65%	Underperform Votes 213 34.35%
Third Coast Bancshares	Outperform Votes 14 53.85%	Underperform Votes 12 46.15%

Is CLLS or TCBX more profitable?

Third Coast Bancshares has a net margin of 13.23% compared to Cellectis' net margin of -234.39%. Third Coast Bancshares' return on equity of 10.14% beat Cellectis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellectis	-234.39%	-74.55%	-22.65%
Third Coast Bancshares	13.23%	10.14%	0.96%

Which has preferable valuation and earnings, CLLS or TCBX?

Third Coast Bancshares has higher revenue and earnings than Cellectis. Cellectis is trading at a lower price-to-earnings ratio than Third Coast Bancshares, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellectis	$9.19M	11.55	-$101.06M	-$1.30	-1.47
Third Coast Bancshares	$274.75M	1.78	$33.40M	$2.55	13.98

Summary

Cellectis beats Third Coast Bancshares on 9 of the 17 factors compared between the two stocks.